18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer
复制标题
DOI:
10.3748/wjg.v17.i2.231
复制
发表时间:
2011-01-14
影响因子:
4.3
通讯作者:
Suzuki, Yasuyuki
中科院分区:
文献类型:
--
作者:
Okano, Keiichi;Kakinoki, Keitaro;Suzuki, Yasuyuki
AIM: To investigate the role of F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) in the diagnosis of small pancreatic cancer.METHODS: This study involved 31 patients with proven invasive ductal cancer of the pancreas. The patients were divided into 3 groups according to the maximum diameter of the tumor: TS1 (maximum tumor size 2.0 cm and 4.0 cm). The relationships between the TS and various diagnostic tools, including FDG-PET with dual time point evaluation, were analyzed.RESULTS: The tumors ranged from 1.3 to 11.0 cm in diameter. Thirty of the 31 patients (97%) had a positive FDG-PET study. There were 5 patients classified as TS1, 15 as TS2 and 11 as TS3-4. The sensitivity of FDG-PET, computed tomography (CT) and magnetic resonance imaging (MRI) were 100%, 40%, 0% in TS1, 93%, 93%, 89% in TS2 and 100%, 100%, 100% in TS3-4. The sensitivity of FDG-PET was significantly higher in comparison to CT and MRI in patients with TS1 (P < 0.032). The mean standardized uptake values (SUVs) did not show a significant difference in relation to the TS (TS1: 5.8 +/- 4.5, TS2: 5.7 +/- 2.2, TS3-4: 8.2 +/- 3.9), respectively. All the TS1 tumors (from 13 to 20 mm) showed higher SUVs in FDG-PET with dual time point evaluation in the delayed phase compared with the early phase, which suggested the lesions were malignant.CONCLUSION: These results indicate that FDG-PET with dual time point evaluation is a useful modality for the detection of small pancreatic cancers with a diameter of less than 20 mm. (C) 2011 Baishideng. All rights reserved.